Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenal Insufficiency × Prednisone × 30 days × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 19 Lymphoma, Large B-Cell, Diffuse 13 Burkitt Lymphoma 12 Lymphoma, Follicular 9 Lymphoma 9 Lymphoma, Non-Hodgkin 7 Prostatic Neoplasms, Castration-Resistant 5 Neoplasms 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3 Lymphoma, B-Cell, Marginal Zone 3 Hodgkin Disease 3 Waldenstrom Macroglobulinemia 2 Recurrence 2 Myasthenia Gravis 2 Hematologic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Vasculitis, Central Nervous System 1 Urogenital Neoplasms 1 Triple Negative Breast Neoplasms 1 Stiff-Person Syndrome 1 Skin Neoplasms 1 Rasmussen subacute encephalitis 1 Prostate Cancer Metastatic 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Polyradiculoneuropathy, Chronic Inflammatory Demyelinating 1 Plasmablastic Lymphoma 1 Ovarian Neoplasms 1 Opsoclonus-Myoclonus Syndrome 1

Interventions

ravulizumab 1 Prednisone 1 Prednisolone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07221838 2026-03-03

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Not yet recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡